Cimzia (CIM-zee-uh) is a new biologic therapy for Crohn's disease

June 2008

Cimzia (CIM-zee-uh) is a new biologic therapy for Crohn's disease.

Cimzia (certolizumab pegol) is a tumor necrosis factor blocker... similar to Humira (adalimumab) and Remicade (infliximab).

Cimzia is "PEGylated" to extend its half-life. It can be given every 4 weeks...instead of every 2 weeks like Humira.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote